Elevance Health Basic EPS 2010-2024 | ELV
Elevance Health annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Elevance Health basic eps for the quarter ending December 31, 2024 was $, a 100% decline year-over-year.
- Elevance Health basic eps for the twelve months ending December 31, 2024 was $23.94, a 5.67% decline year-over-year.
- Elevance Health annual basic eps for 2024 was $0B, a 100% decline from 2023.
- Elevance Health annual basic eps for 2023 was $0.025B, a 3.34% increase from 2022.
- Elevance Health annual basic eps for 2022 was $0.025B, a 2.77% decline from 2021.
| Elevance Health Annual Basic EPS | |
|---|---|
| 2024 | $ |
| 2023 | $25.38 |
| 2022 | $24.56 |
| 2021 | $25.26 |
| 2020 | $18.23 |
| 2019 | $18.81 |
| 2018 | $14.53 |
| 2017 | $14.70 |
| 2016 | $9.39 |
| 2015 | $9.73 |
| 2014 | $9.31 |
| 2013 | $8.34 |
| 2012 | $8.26 |
| 2011 | $7.35 |
| 2010 | $7.03 |
| 2009 | $9.96 |
| Elevance Health Quarterly Basic EPS | |
|---|---|
| 2024-12-31 | |
| 2024-09-30 | $4.38 |
| 2024-06-30 | $9.91 |
| 2024-03-31 | $9.65 |
| 2023-12-31 | $3.70 |
| 2023-09-30 | $5.48 |
| 2023-06-30 | $7.83 |
| 2023-03-31 | $8.37 |
| 2022-12-31 | $3.66 |
| 2022-09-30 | $6.69 |
| 2022-06-30 | $6.80 |
| 2022-03-31 | $7.41 |
| 2021-12-31 | $4.93 |
| 2021-09-30 | $6.20 |
| 2021-06-30 | $7.33 |
| 2021-03-31 | $6.80 |
| 2020-12-31 | $2.30 |
| 2020-09-30 | $0.88 |
| 2020-06-30 | $9.02 |
| 2020-03-31 | $6.03 |
| 2019-12-31 | $3.70 |
| 2019-09-30 | $4.64 |
| 2019-06-30 | $4.44 |
| 2019-03-31 | $6.03 |
| 2018-12-31 | $1.63 |
| 2018-09-30 | $3.70 |
| 2018-06-30 | $4.07 |
| 2018-03-31 | $5.13 |
| 2017-12-31 | $4.78 |
| 2017-09-30 | $2.87 |
| 2017-06-30 | $3.23 |
| 2017-03-31 | $3.82 |
| 2016-12-31 | $1.38 |
| 2016-09-30 | $2.35 |
| 2016-06-30 | $2.97 |
| 2016-03-31 | $2.69 |
| 2015-12-31 | $0.70 |
| 2015-09-30 | $2.51 |
| 2015-06-30 | $3.27 |
| 2015-03-31 | $3.25 |
| 2014-12-31 | $1.90 |
| 2014-09-30 | $2.31 |
| 2014-06-30 | $2.64 |
| 2014-03-31 | $2.46 |
| 2013-12-31 | $0.54 |
| 2013-09-30 | $2.21 |
| 2013-06-30 | $2.67 |
| 2013-03-31 | $2.92 |
| 2012-12-31 | $1.57 |
| 2012-09-30 | $2.17 |
| 2012-06-30 | $1.96 |
| 2012-03-31 | $2.56 |
| 2011-12-31 | $1.03 |
| 2011-09-30 | $1.92 |
| 2011-06-30 | $1.92 |
| 2011-03-31 | $2.48 |
| 2010-12-31 | $1.45 |
| 2010-09-30 | $1.86 |
| 2010-06-30 | $1.73 |
| 2010-03-31 | $1.99 |
| 2009-12-31 | $5.80 |
| 2009-09-30 | $1.55 |
| 2009-06-30 | $1.44 |
| 2009-03-31 | $1.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $90.846B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.052B | 27.37 |
| CVS Health (CVS) | United States | $83.717B | 12.25 |
| Cencora (COR) | United States | $47.591B | 17.27 |
| DiDi Global (DIDIY) | China | $23.087B | 0.00 |
| Natera (NTRA) | United States | $22.788B | 0.00 |
| ICON (ICLR) | Ireland | $15.783B | 14.04 |
| Doximity (DOCS) | United States | $14.316B | 74.45 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Revvity (RVTY) | United States | $13.997B | 23.47 |
| Viatris (VTRS) | United States | $13.046B | 4.02 |
| Solventum (SOLV) | United States | $12.780B | 0.00 |
| Avantor (AVTR) | United States | $12.038B | 17.68 |
| CochLear (CHEOY) | Australia | $11.471B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
| HealthEquity (HQY) | United States | $9.860B | 49.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
| Organon (OGN) | United States | $3.938B | 4.01 |
| Sotera Health (SHC) | United States | $3.861B | 20.65 |
| BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
| Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
| GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
| Concentras Parent (CON) | United States | $2.973B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
| Progyny (PGNY) | United States | $2.017B | 40.85 |
| PACS (PACS) | United States | $2.006B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
| Premier (PINC) | United States | $1.711B | 10.96 |
| Agilon Health (AGL) | United States | $1.471B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.325B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
| Embecta (EMBC) | United States | $0.899B | 6.16 |
| Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
| DocGo (DCGO) | United States | $0.562B | 21.19 |
| Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| MultiPlan (MPLN) | United States | $0.476B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.440B | 38.09 |
| Nutex Health (NUTX) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.345B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.138B | 0.00 |
| So-Young (SY) | China | $0.118B | 19.98 |
| IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
| ModivCare (MODV) | United States | $0.082B | 4.46 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |